in this issue
Regions :: North America :: U.S.
EPA rolls out endocrine disruptor research effort to assess low-dose effects
9:29 AM MST | December 17, 2012 | Kara Sissell
EPA says it is working on a “state of the science” paper to update its research on low-dose health effects for endocrine disruptors. The findings will provide information to help inform how EPA assesses the safety of chemicals by determining if the current methods used adequately portray possible certain links between levels of exposure and adverse health effects, the agency says. Risk assessments for low-dose effects—or nonmonotonic dose response curves (NMDRC)—for endocrine disruptors have generated considerable differences of opinion...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee